文献速递免疫规划

病毒载体疫苗保护玄凤鹦鹉免受异源鹦鹉博尔纳病毒2型攻击感染后的炎性病变

Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection.
PubMed 文献 · Vaccine · 2016-12-22

本研究优化禽博尔纳病毒疫苗接种与感染模型,发现鹦鹉博尔纳病毒2型经肌内和皮下联合注射仅需102.7个焦点形成单位即可感染玄凤鹦鹉,而经口和眼鼻途径给予500倍剂量未导致持续感染。用表达PaBV-4核蛋白和磷蛋白基因的新城疫病毒(NDV)和改良安卡拉痘苗病毒(MVA)载体疫苗初免-加强免疫玄凤鹦鹉,可显著阻断异源PaBV-2攻击后的病毒复制,仅1只接种鸟出现轻度前胃扩张病相关显微病变。

要点

  • PaBV-2经肌内和皮下联合注射102.7 ffu即可感染玄凤鹦鹉,经口和眼鼻途径500倍剂量未致持续感染。
  • NDV和MVA载体疫苗初免-加强免疫后,6只接种鸟中仅2只少数器官可检出极低病毒水平。
  • 仅1只接种鸟出现轻度PDD相关显微病变,而未接种对照鸟未获保护。

核心结论

  • NDV和MVA载体疫苗可保护玄凤鹦鹉免受异源博尔纳病毒攻击感染及后续PDD。
  • 这些载体疫苗是应对鹦鹉种群禽博尔纳病毒的有前景工具。

研究设计与样本

  • 研究用玄凤鹦鹉(Nymphicus hollandicus)比较不同途径和剂量的PaBV-2感染,并进行NDV和MVA载体疫苗初免-加强免疫后异源PaBV-2攻击实验。
  • 攻击感染用PaBV-2 103.5 ffu经胃肠外途径,接种组6只、模拟接种对照组若干。

主要发现

  • PaBV-2经肌内和皮下联合注射102.7 ffu即可感染玄凤鹦鹉,而经口和眼鼻途径给予500倍剂量未导致持续感染。
  • NDV和MVA载体疫苗初免-加强免疫后,6只接种鸟中仅2只少数器官可检出极低病毒水平。
  • 仅1只接种鸟出现轻度PDD相关显微病变,模拟接种对照鸟未获保护,出现PaBV-2感染和炎症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Avian bornaviruses are causative agents of proventricular dilatation disease (PDD), a chronic neurologic and often fatal disorder of psittacines including endangered species. To date no causative therapy or immunoprophylaxis is available. Our previous work has shown that viral vector vaccines can delay the course of homologous bornavirus challenge infections but failed to protect against PDD when persistent infection was not prevented. The goal of this study was to refine our avian bornavirus vaccination and infection model to better represent natural bornavirus infections in order to achieve full protection against a heterologous challenge infection. We observed that parrot bornavirus 2 (PaBV-2) readily infected cockatiels (Nymphicus hollandicus) by combined intramuscular and subcutaneous injection with as little as 102.7foci-forming units (ffu) per bird, whereas a 500-fold higher dose of the same virus administered via peroral and oculonasal route did not result in persistent infection. These results indicated that experimental bornavirus challenge infections with this virus should be performed via the parenteral route. Prime-boost vaccination of cockatiels with Newcastle disease virus (NDV) and modified vaccinia virus Ankara (MVA) vectors expressing the nucleoprotein and phosphoprotein genes of PaBV-4 substantially blocked bornavirus replication following parenteral challenge infection with 103.5ffu of heterologous PaBV-2. Only two out of six vaccinated birds had very low viral levels detectable in a few organs. As a consequence, only one vaccinated bird developed mild PDD-associated microscopic lesions, while mock-vaccinated controls were not protected against PaBV-2 infection and inflammation. Our results demonstrate that NDV and MVA vector vaccines can protect against invasive heterologous bornavirus challenge infections and subsequent PDD. These vector vaccines represent a promising tool to combat avian bornaviruses in psittacine populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Runge S, Olbert M, Herden C, et al. Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection. Vaccine. 2016. PMID: 28017426. doi:10.1016/j.vaccine.2016.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。